Our top pick for
China Jo-Jo Drugstores, Inc is a pharmaceutical retailers business based in the US. China Jo-Jo Drugstores shares (CJJD) are listed on the NASDAQ and all prices are listed in US Dollars. China Jo-Jo Drugstores employs 1,014 staff and has a trailing 12-month revenue of around USD$127.8 million.
|52-week range||USD$0.8 - USD$3.46|
|50-day moving average||USD$1.2112|
|200-day moving average||USD$1.0668|
|Wall St. target price||USD$7|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$0.005|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing China Jo-Jo Drugstores stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of China Jo-Jo Drugstores's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
China Jo-Jo Drugstores's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 69x. In other words, China Jo-Jo Drugstores shares trade at around 69x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
China Jo-Jo Drugstores's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$1.9 million.
The EBITDA is a measure of a China Jo-Jo Drugstores's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$127.8 million|
|Gross profit TTM||USD$25.5 million|
|Return on assets TTM||-7.21%|
|Return on equity TTM||-46.99%|
|Market capitalisation||USD$46.3 million|
TTM: trailing 12 months
There are currently 438,266 China Jo-Jo Drugstores shares held short by investors – that's known as China Jo-Jo Drugstores's "short interest". This figure is 78.4% up from 245,699 last month.
There are a few different ways that this level of interest in shorting China Jo-Jo Drugstores shares can be evaluated.
China Jo-Jo Drugstores's "short interest ratio" (SIR) is the quantity of China Jo-Jo Drugstores shares currently shorted divided by the average quantity of China Jo-Jo Drugstores shares traded daily (recently around 1.5 million). China Jo-Jo Drugstores's SIR currently stands at 0.3. In other words for every 100,000 China Jo-Jo Drugstores shares traded daily on the market, roughly 300 shares are currently held short.
However China Jo-Jo Drugstores's short interest can also be evaluated against the total number of China Jo-Jo Drugstores shares, or, against the total number of tradable China Jo-Jo Drugstores shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case China Jo-Jo Drugstores's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 China Jo-Jo Drugstores shares in existence, roughly 10 shares are currently held short) or 0.0159% of the tradable shares (for every 100,000 tradable China Jo-Jo Drugstores shares, roughly 16 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against China Jo-Jo Drugstores.
Find out more about how you can short China Jo-Jo Drugstores stock.
We're not expecting China Jo-Jo Drugstores to pay a dividend over the next 12 months.
China Jo-Jo Drugstores's shares were split on a 1:2 basis on 14 April 2010. So if you had owned 2 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your China Jo-Jo Drugstores shares – just the quantity. However, indirectly, the new 100% higher share price could have impacted the market appetite for China Jo-Jo Drugstores shares which in turn could have impacted China Jo-Jo Drugstores's share price.
Over the last 12 months, China Jo-Jo Drugstores's shares have ranged in value from as little as $0.8 up to $3.46. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while China Jo-Jo Drugstores's is 0.4525. This would suggest that China Jo-Jo Drugstores's shares are less volatile than average (for this exchange).
China Jo-Jo Drugstores, Inc., together with its subsidiaries, operates as a retailer and distributor of pharmaceutical and other healthcare products in the People's Republic of China. The company operates through four segments: Retail Drugstores, Online Pharmacy, Drug Wholesale, and Herb Farming. Its stores provide various pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products, such as consumable, seasonal, and promotional items. The company also operates licensed doctors of Western medicine and TCM on site for consultation, examination, and treatment of common ailments at scheduled hours. In addition, it operates dada360.com, an online drugstore that retails OTC drugs and nutritional supplements, as well as sells products through third-party platforms, such as Tmall, JD.com, and Amazon.com. Further, the company distributes third-party pharmaceutical products primarily to trading companies, as well as cultivates and wholesales herbs used for TCM. As of March 31, 2020, it had 118 retail pharmacies under the Jiuzhou Grand Pharmacy name, as well as 10 drugstores. The company was founded in 2003 and is headquartered in Hangzhou, the People's Republic of China.
Everything we know about the Achilles Therapeutics plc IPO, plus information on how to buy in.
Everything we know about the SEMrush Holdings Inc IPO, plus information on how to buy in.
Everything we know about the ChargePoint IPO, plus information on how to buy in.
Everything we know about the Kaltura Inc IPO, plus information on how to buy in.
Everything we know about the Rocket Lab IPO, plus information on how to buy in.
Everything we know about the Soho House IPO, plus information on how to buy in.
Everything we know about the VIZIO IPO, plus information on how to buy in.
Everything we know about the IDW Media Holdings Inc IPO, plus information on how to buy in.
Everything we know about the Karooooo Ltd IPO, plus information on how to buy in.
Everything we know about the Connect Biopharma Holdings Limited IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.